Number of Cardiologists per Cardiovascular Beds and In‐Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan

Background Little evidence is available about the number of cardiologists required for appropriate treatment of heart failure (HF). Our objective was to determine the association between the number of cardiologists per cardiology beds for treating patients with acute HF and in‐hospital mortality. Methods and Results This was a cross‐sectional study, and we used the Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination discharge database. The data of patients with HF on emergency admission from April 1, 2012, to March 31, 2014, were extracted. The patients were categorized into 4 groups by the quartiles of the numbers of cardiologists per 50 cardiovascular beds (first group: median, 4.4 [interquartile range, 3.5–5.0]; second group: median, 6.7 [interquartile range, 6.5–7.5]; third group: median, 9.7 [interquartile range, 8.8–10.1]; and fourth group: median, 16.7 [interquartile range, 14.0–23.8]). Using multilevel mixed‐effect logistics regression, we determined adjusted odds ratios for in‐hospital mortality. We identified 154 290 patients with HF on emergency admissions. There were 29 626, 36 587, 46 451, and 41 626 patients in the first, second, third, and fourth groups, respectively. HF severity, on the basis of New York Heart Association classification, was similar in the 3 groups. Adjusted odds ratios (95% CIs) for in‐hospital mortality were 0.92 (0.82–1.04; P=0.20), 0.82 (0.72–0.92; P<0.001), and 0.70 (0.61–0.80; P<0.001) for the second, third, and fourth groups, respectively. The proportion of medication used, including angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, β blockers, and mineralocorticoid receptor antagonists, was positively correlated to the number of cardiologists. Conclusions Patients hospitalized for HF in hospitals with larger numbers of cardiologists per cardiovascular beds had lower 30‐day mortality.

[1]  S. Normand,et al.  Hospital volume and 30-day mortality for three common medical conditions. , 2010, The New England journal of medicine.

[2]  S. Yasuda,et al.  Current Status of Cardiovascular Medicine in the Aging Society of Japan. , 2018, Circulation.

[3]  S. Saba,et al.  Trends in hospitalization for congestive heart failure, 1996–2009 , 2017, Clinical cardiology.

[4]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[5]  H. Shimokawa,et al.  Chronic heart failure in Japan: Implications of the CHART studies , 2008, Vascular health and risk management.

[6]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[7]  D. Mozaffarian,et al.  National Trends in Admission and In‐Hospital Mortality of Patients With Heart Failure in the United States (2001–2014) , 2017, Journal of the American Heart Association.

[8]  G. Ogedegbe,et al.  Heart failure–associated hospitalizations in the United States. , 2013, Journal of the American College of Cardiology.

[9]  Kazuhiko Ohe,et al.  Impact of the Japanese Diagnosis Procedure Combination-based Payment System on cardiovascular medicine-related costs. , 2005, International heart journal.

[10]  Bernd Weissmuller,et al.  Trials , 2020, Israelpolitik.

[11]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[12]  Harry Hemingway,et al.  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals , 2017, The Lancet.

[13]  K. Yoneyama,et al.  Effect of PM2.5 for hospitalization of cardiovascular diseases and medical expenses by age group: a nationwide study from the Japanese Registry Of All cardiac and vascular Diseases (JROAD) , 2020 .

[14]  J. Wise Acute heart failure patients should be seen by specialist teams, says NICE , 2014, BMJ : British Medical Journal.

[15]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[16]  Maarten Uyttenboogaart,et al.  Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials , 2005, Stroke.

[17]  I. Komuro,et al.  The Current Status of Cardiovascular Medicine in Japan - Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[18]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[19]  E. Philbin,et al.  Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. , 1999, Chest.

[20]  A. Jha,et al.  Physician Volume, Specialty, and Outcomes of Care for Patients With Heart Failure , 2013, Circulation. Heart failure.

[21]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[22]  K. Fushimi,et al.  The relationship between the number of cardiologists and clinical practice patterns in acute heart failure: a cross-sectional observational study , 2014, BMJ Open.

[23]  Ruoxiang Jiang,et al.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. , 2015, JAMA internal medicine.